Search - tctmd.com

Displaying 101 - 120 of 126

Sort: Relevancy | Date

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

Presentation TCT 2013

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Presenter: Michael Ezekowitz

October 31, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

Reversal Strategies Warfarin and the New Oral Anticoagulants: How Necessary, How Fast, How Safe, How Effective?

Presenter: Kurt Huber

October 31, 2013

Presentation TCT 2013

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Presenter: Ori Ben-Yehuda

October 31, 2013

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

Dual Anti-Platelet Therapy Plus the New Chronic Oral Anticoagulants: What Do We Know?

Presenter: Pascal Vranckx

October 31, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

Presentation TCT 2013

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

Presenter: Christopher Granger

October 27, 2013

Presentation TCT 2013

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Presenter: Michael Ezekowitz

October 27, 2013

Presentation TCT 2013

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Presenter: Andr?s Kom?csi, Andr?s Vorobcsuk, D?niel Kehl, Daniel Aradi

January 31, 2013

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presenter: Jonathan Halperin

October 25, 2012

Presentation TCT 2012

Part 1: Oral Anticoagulants

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

Advertisement

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Reversal Strategies Warfarin and the New Oral Anticoagulants: How Necessary, How Fast, How Safe, How Effective?

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Dual Anti-Platelet Therapy Plus the New Chronic Oral Anticoagulants: What Do We Know?

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Experts Discuss Efficacy, Safety of Watchman Device

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Stroke Prevention Strategies Discussed

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Part 1: Oral Anticoagulants

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content